Result Number | Material Type | Add to My Shelf Action | Record Details and Options |
---|---|---|---|
1 |
Material Type: Dataset
|
![]() |
A Phase II signal-seeking trial targeting recurrent high grade serous ovarian cancer (HGSC) with Cyclin E1 (CCNE1) over-expression with and without gene amplification - IGNITEAu-Yeung, George ; Australia New Zealand Gynaecological Oncology Group (ANZGOG)Australia New Zealand Gynaecological Oncology Group 2027Texto completo disponível |
2 |
Material Type: Dataset
|
![]() |
An investigator-initiated, non-randomised, phase II study of combination CTLA-4 and PD-L1 blockade in combination with HER2 blockade in advanced HER2-positive breast cancers that have progressed on prior trastuzumab-based therapy (BCT 1703 DIAmOND)Loi, Sherene ; Breast Cancer Trials (BCT)Breast Cancer Trials (BCT) 2026Texto completo disponível |
3 |
Material Type: Dataset
|
![]() |
Western Blots for Oncogenic fatty acid oxidation senses sleep deficiency-induced circadian disruption to promote tumorigenesislu, jinxinMendeley Data 2026Texto completo disponível |
4 |
Material Type: Artigo
|
![]() |
Recent advcances on plant-based bioengineered nanoparticles using secondary metabolites and their potential in lung cancer managementIslam, Atiqul ; Rahat, Iqra ; Anurag ; Rejeeth, Chandrababu ; Sharma, Devkant ; Sharma, AlokJournal of future foods, 2025-03, Vol.5 (1), p.1-20 [Periódico revisado por pares]Elsevier B.VTexto completo disponível |
5 |
Material Type: Artigo
|
![]() |
Predictive biomarkers for immunotherapy response in extensive-stage SCLCZhu, Lin ; Qin, JingJournal of cancer research and clinical oncology, 2025-01, Vol.150 (1), p.22-22, Article 22 [Periódico revisado por pares]Berlin/Heidelberg: Springer Berlin HeidelbergTexto completo disponível |
6 |
Material Type: Artigo
|
![]() |
Efficacy and safety of first-line therapy in patients with HER2-positive advanced breast cancer: a network meta-analysis of randomized controlled trialsWang, Junxiao ; Yu, Yushuai ; Lin, Qisheng ; Zhang, Jie ; Song, ChuanguiJournal of cancer research and clinical oncology, 2025-01, Vol.150 (1), p.21-21, Article 21 [Periódico revisado por pares]Berlin/Heidelberg: Springer Berlin HeidelbergTexto completo disponível |
7 |
Material Type: Artigo
|
![]() |
Vemurafenib combined with chemotherapy achieved sustained remission in pediatric LCH: a multi-center observational studyLei, Jiaying ; Wang, Wenxia ; Lin, Danna ; Zhu, Chengguang ; Jia, Wenguang ; Weng, Wenjun ; Liu, Xiaoshan ; Ma, Yuhan ; Wang, Zhixuan ; Yang, Lihua ; He, Xiangling ; He, Yunyan ; LI, YangJournal of cancer research and clinical oncology, 2025-01, Vol.150 (1), p.12-12, Article 12 [Periódico revisado por pares]Berlin/Heidelberg: Springer Berlin HeidelbergTexto completo disponível |
8 |
Material Type: Artigo
|
![]() |
Natural products targeting the MAPK-signaling pathway in cancer: overviewShi, Aiwen ; Liu, Li ; Li, Shuang ; Qi, BinJournal of cancer research and clinical oncology, 2025-01, Vol.150 (1), p.6-6, Article 6 [Periódico revisado por pares]Berlin/Heidelberg: Springer Berlin HeidelbergTexto completo disponível |
9 |
Material Type: Artigo
|
![]() |
Analysis of laboratory parameters before the occurrence of hepatic sinusoidal obstruction syndrome in children, adolescents, and young adults after hematopoietic stem cell transplantationJohann, Lorena ; Gruhn, BerndJournal of cancer research and clinical oncology, 2025-01, Vol.150 (1), p.9-9, Article 9 [Periódico revisado por pares]Berlin/Heidelberg: Springer Berlin HeidelbergTexto completo disponível |
10 |
Material Type: Artigo
|
![]() |
Long-term survival of stage IV melanoma patients: evaluation on 640 melanoma patients entering stage IV between 2014 and 2017Reitmajer, Markus ; Leiter, Ulrike ; Nanz, Lena ; Amaral, Teresa ; Flatz, Lukas ; Garbe, Claus ; Forschner, AndreaJournal of cancer research and clinical oncology, 2025-01, Vol.150 (1), p.15-15, Article 15 [Periódico revisado por pares]Berlin/Heidelberg: Springer Berlin HeidelbergTexto completo disponível |